National Drug Abuse Treatment Clinical Trials Network   Report issue

Foundation Phase 2
Founded: United States (1999)

Organization Overview

First Clinical Trial
2020
NCT04225598
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

National Drug Abuse Treatment Clinical Trials Network

Active Ingredients

Drugs in Phase 2 Trials (1)

buprenorphine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Emergencies (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1